Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Airware Labs Corp. (OTC: AIRW).

Full DD Report for AIRW

You must become a subscriber to view this report.


Recent News from (OTC: AIRW)

Airware Labs Announces Name Change to Item 9 Labs Corp. and New Ticker Symbol "INLB"
SCOTTSDALE, Ariz., April 26, 2018 (GLOBE NEWSWIRE) -- Airware Labs Corp (OTC:AIRW) (“Airware” or the “Company”), is pleased to announce that today the Financial Industry and Regulatory Authority (“FINRA”) has approved the Company’s previous...
Source: GlobeNewswire
Date: April, 26 2018 17:00
Airware Labs Announces Name Change to Item 9 Labs Corp. and Files for Ticker Symbol Change with FINRA
Follows Closing of Item 9 Labs Acquisition and $1 Million Definitive Financing Agreement Bryce Skalla to Serve as Chief Executive Officer, Jessica Smith as Chief Financial Officer and Jeffrey Rassás as Chief Strategic Officer SCOTTSDALE, Ariz., April 05, 2018 (GLOBE NEWSWI...
Source: GlobeNewswire
Date: April, 05 2018 09:00
Airware Labs Announces Item 9 Labs Awarded 1st Place in Two Categories at Arizona's 2018 ERRL Cup
SCOTTSDALE, Ariz., March 28, 2018 (GLOBE NEWSWIRE) -- Airware Labs Corporation  (OTC:AIRW) (“Airware” or the “Company”) today announced that its wholly-owned subsidiary BSSD Group, LLC, doing business as Item 9 Labs, was named among Arizona's 2018 ERRL Cu...
Source: GlobeNewswire
Date: March, 28 2018 09:00
Airware Labs Completes Acquisition of Item 9 Labs
SCOTTSDALE, Ariz., March 21, 2018 (GLOBE NEWSWIRE) -- Airware Labs Corporation  (OTC:AIRW) (“Airware” or the “Company”) today announced the closing of its acquisition of BSSD Group, LLC, doing business as Item 9 Labs, completed through a share exchange ag...
Source: GlobeNewswire
Date: March, 21 2018 09:00
Airware Labs Corp Enters Into Letter of Intent to Acquire Item 9 Labs
SCOTTSDALE, Arizona , November 30, 2017 /PRNewswire/ -- Airware Labs Corporation (OTC: AIRW) today announced entering into a non-binding letter of intent ("LOI") to acquire BSSD Group, LLC doing business as Item 9 Labs and other transactions related to the acquisition. Terms of the LO...
Source: PR Newswire
Date: November, 30 2017 09:00
Breathe Right Nasal Strips Powerhouse Dr. Dan Cohen Named Airware Labs President
Breathe Right Nasal Strips Powerhouse Dr. Dan Cohen Named Airware Labs President
Source: OTC Markets
Date: August, 19 2015 00:00
Airware Labs Continues to Expand into New Markets with Sales in South Korea
Airware Labs Continues to Expand into New Markets with Sales in South Korea
Source: OTC Markets
Date: August, 18 2015 00:00

 


About Airware Labs Corp. (OTC: AIRW)

Logo for Airware Labs Corp. (OTC: AIRW)

AirWare Labs www.airwarelabs.com provides patented amp innovative technology solutions to consumer products promoting better health and enhanced well being. AirWare Labs products are marketed under the family name of AIR by AirWare Labs. AIR Products start with an FDA approved medical grade silicone molded as an intranasal Air Breathe dilator this is the AIR delivery system. This microstructure enhances normal nasal airflow with every breath proven to deliver up to more oxygen. Certain AIR products are infused with essential oils with unique healing properties including antibacterial and therapeutic defense against airborne allergens, viruses and bacteria. AIR Allergy and Travel products have additional defense in the form of an integrated filter media from M to remove microscopic particles that carry viruses, Allergens and bacteria. Other AIR products specialize in helping with congestion, insomnia, headaches, nausea, snoring and performance enhancements.

 

 

 

Current Management

  • Jeffrey Rassas / CEO
  • Daniel E. Cohen MD, Ph.D. / President, CMO
    • Dr. Daniel Cohen is a neurologist, inventor and author with a focus on writing and technology for personal and spiritual development. He authored the book, Addicted To My Ego and coauthored Claim Your Basic Rights, Create a Practical Partnership with Your Soul and Claim Your Basic Rights, Embody Your Soul with Jennifer Palmquist and presently teaches personal and spiritual development.
  • Jessica Smith / CFO, Secretary, Treasurer
  • Ronald Miller, Jr. /
  • Daniel E. Cohen MD, Ph.D. / Dr. Daniel Cohen is a neurologist, inventor and author with a focus on writing and technology for personal and spiritual development. He authored the book, Addicted To My Ego and coauthored Claim Your Basic Rights, Create a Practical Partnership with Your Soul and Claim Your Basic Rights, Embody Your Soul with Jennifer Palmquist and presently teaches personal and spiritual development.

Current Share Structure

  • Market Cap: $14,542,722 - 03/09/2018
  • Authorized: 200,000,000 - 02/28/2018
  • Issue and Outstanding: 153,081,283 - 02/28/2018
  • Float: 14,778,931 - 01/09/2015

 


Recent Filings from (OTC: AIRW)

Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: April, 05 2018
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: January, 30 2018
Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current InformFiling Source: OTC Markets
Filing Date: January, 16 2018
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: January, 03 2018
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: December, 29 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: August, 01 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: May, 09 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: February, 10 2017
Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current InformFiling Source: OTC Markets
Filing Date: January, 24 2017
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: January, 17 2017

 

 


Daily Technical Chart for (OTC: AIRW)

Daily Technical Chart for (OTC: AIRW)


Stay tuned for daily updates and more on (OTC: AIRW)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AIRW)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AIRW is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of AIRW and does not buy, sell, or trade any shares of AIRW. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/